loadpatents
Patent applications and USPTO patent grants for ZULLI; Allison L..The latest application filed is for "solid forms of an orally-delivered beta-lactamase inhibitor and uses thereof".
Patent | Date |
---|---|
Solid Forms Of An Orally-delivered Beta-lactamase Inhibitor And Uses Thereof App 20220194964 - BURNS; Christopher J. ;   et al. | 2022-06-23 |
Penicillin-binding protein inhibitors Grant 11,332,485 - Burns , et al. May 17, 2 | 2022-05-17 |
Spiropiperidine Derivatives App 20210284651 - Hudkins; Robert L. ;   et al. | 2021-09-16 |
1,4-Substituted Piperidine Derivatives App 20210230116 - Becknell; Nadine C. ;   et al. | 2021-07-29 |
Penicillin-binding Protein Inhibitors App 20210198288 - BURNS; Christopher J. ;   et al. | 2021-07-01 |
Spiropiperidine derivatives Grant 11,046,707 - Hudkins , et al. June 29, 2 | 2021-06-29 |
1,4-substituted piperidine derivatives Grant 10,851,057 - Becknell , et al. December 1, 2 | 2020-12-01 |
Penicillin-binding Protein Inhibitors App 20200157123 - BURNS; Christopher J. ;   et al. | 2020-05-21 |
Spiropiperidine Derivatives App 20200031840 - HUDKINS; Robert L. ;   et al. | 2020-01-30 |
Beta-lactamase inhibitors Grant 10,464,952 - Burns , et al. No | 2019-11-05 |
Azaquinazoline inhibitors of atypical protein kinase C Grant 10,414,763 - Dorsey , et al. Sept | 2019-09-17 |
1,4-substituted Piperidine Derivatives App 20190152913 - Becknell; Nadine C. ;   et al. | 2019-05-23 |
1,4-substituted piperidine derivatives Grant 10,221,135 - Becknell , et al. | 2019-03-05 |
Beta-lactamase Inhibitors App 20180291039 - BURNS; Christopher J. ;   et al. | 2018-10-11 |
1,4-substituted Piperidine Derivatives App 20180179159 - Becknell; Nadine C. ;   et al. | 2018-06-28 |
Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use App 20180148447 - HUDKINS; Robert L. ;   et al. | 2018-05-31 |
Azaquinazoline inhibitors of Atypical protein Kinase C Grant 9,914,730 - Breslin , et al. March 13, 2 | 2018-03-13 |
Pyrazolo[1,5-a]pyridine derivatives and methods of their use Grant 9,914,731 - Hudkins , et al. March 13, 2 | 2018-03-13 |
1,4-substituted piperidine derivatives Grant 9,902,696 - Becknell , et al. February 27, 2 | 2018-02-27 |
Azaquinazoline inhibitors of atypical protein kinase C Grant 9,896,446 - Breslin , et al. February 20, 2 | 2018-02-20 |
1,4-substituted Piperidine Derivatives App 20160368874 - Becknell; Nadine C. ;   et al. | 2016-12-22 |
Pyrazolo[1,5-a]pyridine Derivatives And Methods Of Their Use App 20160318929 - Hudkins; Robert L ;   et al. | 2016-11-03 |
Azaquinazoline Inhibitors of Atypical Protein Kinase C App 20160102094 - Breslin; Henry J. ;   et al. | 2016-04-14 |
Azaquinazoline Inhibitors Of Atypical Protein Kinase C App 20150274720 - Dorsey; Bruce D. ;   et al. | 2015-10-01 |
Substituted Phenoxypropylcycloamine Derivatives As Histamine-3 (h3) Receptor Ligands App 20140296212 - Bacon; Edward R. ;   et al. | 2014-10-02 |
Multicyclic compounds and the use thereof Grant 8,716,493 - Chatterjee , et al. May 6, 2 | 2014-05-06 |
Azaquinazoline Inhibitors of Atypical Protein Kinase C App 20140113882 - Breslin; Henry J. ;   et al. | 2014-04-24 |
Methods of treating disorders mediated by histamine H.sub.3 receptors using pyridazinone derivatives Grant 8,673,916 - Bacon , et al. March 18, 2 | 2014-03-18 |
Substituted phenoxypropylcycloamine derivatives as histamine-3 (H.sub.3) receptor ligands Grant 8,648,067 - Bacon , et al. February 11, 2 | 2014-02-11 |
Aryl pyridazinone derivatives and their use as H3 receptor ligands Grant 8,586,588 - Bacon , et al. November 19, 2 | 2013-11-19 |
Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands Grant 8,513,232 - Bacon , et al. August 20, 2 | 2013-08-20 |
Fused pyrrolocarbazoles Grant 8,383,813 - Becknell , et al. February 26, 2 | 2013-02-26 |
Pyridizinone derivatives and the use thereof as H3 inhibitors Grant 8,247,414 - Bacon , et al. August 21, 2 | 2012-08-21 |
Pyridazinone derivatives Grant 8,207,168 - Becknell , et al. June 26, 2 | 2012-06-26 |
Novel Fused Pyrrolocarbazoles App 20120004253 - Becknell; Nadine C. ;   et al. | 2012-01-05 |
Fused pyrrolocarbazoles Grant 8,084,472 - Hudkins , et al. December 27, 2 | 2011-12-27 |
Pyridazinone Derivatives App 20110288075 - Bacon; Edward R. ;   et al. | 2011-11-24 |
Fused pyrrolocarbazoles Grant 8,044,064 - Becknell , et al. October 25, 2 | 2011-10-25 |
Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands App 20110098269 - Becknell; Nadine C. ;   et al. | 2011-04-28 |
Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands App 20110071131 - Bacon; Edward R. ;   et al. | 2011-03-24 |
Novel Multicyclic Compounds And The Use Thereof App 20110059959 - Chatterjee; Sankar ;   et al. | 2011-03-10 |
Pyridazinone Derivatives App 20100280007 - Bacon; Edward R. ;   et al. | 2010-11-04 |
Pyridazinone Derivatives App 20100273779 - Bacon; Edward R. ;   et al. | 2010-10-28 |
Novel Fused Pyrrolocarbazoles App 20100152196 - Becknell; Nadine C. ;   et al. | 2010-06-17 |
Fused pyrrolocarbazoles Grant 7,671,064 - Hudkins , et al. March 2, 2 | 2010-03-02 |
Novel Fused Pyrrolocarbazoles App 20090186888 - Hudkins; Robert L. ;   et al. | 2009-07-23 |
Fused pyrrolocarbazoles Grant 7,514,440 - Hudkins , et al. April 7, 2 | 2009-04-07 |
Novel Fused Pyrrolocarbazoles App 20070203135 - Hudkins; Robert L. ;   et al. | 2007-08-30 |
Fused pyrrolocarbazoles Grant 7,241,779 - Hudkins , et al. July 10, 2 | 2007-07-10 |
Fused pyrrolocarbazoles Grant 7,169,802 - Hudkins , et al. January 30, 2 | 2007-01-30 |
Novel multicyclic compounds and the use thereof App 20060276497 - Chatterjee; Sankar ;   et al. | 2006-12-07 |
Novel fused pyrrolocarbazoles App 20060247294 - Becknell; Nadine C. ;   et al. | 2006-11-02 |
Novel fused pyrrolocarbazoles App 20050143442 - Hudkins, Robert L. ;   et al. | 2005-06-30 |
Novel fused pyrrolocarbazoles App 20050137245 - Hudkins, Robert L. ;   et al. | 2005-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.